<DOC>
	<DOC>NCT02916602</DOC>
	<brief_summary>A phase 3 study to evaluate efficacy and safety of HCP1401</brief_summary>
	<brief_title>A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605</brief_title>
	<detailed_description>A randomized, double-blind, multicenter, phase 3 study to evaluate efficacy and safety of HCP1401 for stage 2 hypertension patients not controlled by HCP0605</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Hypertension patient who satisfied below condition at Visit 1. patient who takes antihypertensive drug 140mmHg &lt;= sitSBP &lt;= 200mmHg patient who doesn't take antihypertensive drug 160mmHg &lt;= sitSBP &lt;= 200mmHg 140mmHg &lt;= sitSBP &lt;= 200mmHg at Visit 2 Patient who have received 4 or more antihypertensive drug Patient with 20mmHg of difference in sitSBP or 10mmHg of difference in sitDBP between 3 times of BP measuring at Visit 1 Patient with sitDBP &gt;= 120mmHg at Visit 2 Patient with secondary hypertension</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>